Colon Cancer Clinical Trial
A Video Intervention to Decrease Patient Fear of Colonoscopy After a Positive Fecal Immunochemical Test
Summary
This clinical trial compares an educational video intervention versus usual care of no video intervention in decreasing patient fear of a colonoscopy procedure after receiving a positive fecal immunochemical test (FIT). The lack of a follow-up colonoscopy after an abnormal FIT result is associated with an increased risk of colorectal cancer mortality, advanced-stage colorectal cancer, among other complications, compared to the completion of a follow-up colonoscopy. An educational video may reduce patient fear and increase knowledge, self-efficacy, and intent to complete a colonoscopy compared to the usual care of no video intervention.
Full Description
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM 1: Patients watch an educational video about the importance of abnormal FIT results, the implications if follow-up colonoscopy is not completed, and demonstrate the steps to complete a colonoscopy.
ARM 2: Patients receive usual care and do not watch the educational video.
After completion of study, patients are followed for 12 months after their abnormal FIT result.
Eligibility Criteria
Inclusion Criteria:
Age 45-75
Have an assigned primary care provider in our partnering safety-net health system
Have a billable primary care encounter between 2019-2022
Have an abnormal FIT result for colorectal cancer (CRC) screening without a colonoscopy within 1 year
Ability to communicate in English due to initial videos being available in English
Exclusion Criteria:
Adults < age 45 or > age 75
Patients who receive care at other University of Washington (UW) medicine sites (non-safety-net patients)
Individuals without a primary care encounter between 2019-2022
Individuals whose primary language is not English
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Seattle Washington, 98109, United States
How clear is this clinincal trial information?
